These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 22482700)

  • 1. Long-term efficacy of infliximab in hidradenitis suppurativa.
    Paradela S; Rodríguez-Lojo R; Fernández-Torres R; Arévalo P; Fonseca E
    J Dermatolog Treat; 2012 Aug; 23(4):278-83. PubMed ID: 22482700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A; Sinclair R; Foley P; Saunders H
    Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.
    Lesage C; Adnot-Desanlis L; Perceau G; Bonnet M; Palot JP; Bernard P; Reguiaï Z
    Eur J Dermatol; 2012; 22(5):640-4. PubMed ID: 22759562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept: effective in the management of hidradenitis suppurativa.
    Cusack C; Buckley C
    Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
    Delage M; Samimi M; Atlan M; Machet L; Lorette G; Maruani A
    Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa.
    Gulliver WP; Jemec GB; Baker KA
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):911-4. PubMed ID: 21605174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa.
    van Rappard DC; Leenarts MF; Meijerink-van 't Oost L; Mekkes JR
    J Dermatolog Treat; 2012 Aug; 23(4):284-9. PubMed ID: 21756155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term infliximab for severe hidradenitis suppurativa.
    Thielen AM; Barde C; Saurat JH
    Br J Dermatol; 2006 Nov; 155(5):1105-7. PubMed ID: 17034567
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
    Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
    J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hidradenitis suppurativa. Response to treatment with infliximab].
    Pedraz J; Daudén E; Pérez-Gala S; Goiriz-Valdés R; Fernández-Peñas P; García-Diez A
    Actas Dermosifiliogr; 2007 Jun; 98(5):325-31. PubMed ID: 17555675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa.
    Miller I; Lynggaard CD; Lophaven S; Zachariae C; Dufour DN; Jemec GB
    Br J Dermatol; 2011 Aug; 165(2):391-8. PubMed ID: 21457202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa.
    Ghias MH; Johnston AD; Kutner AJ; Micheletti RG; Hosgood HD; Cohen SR
    J Am Acad Dermatol; 2020 May; 82(5):1094-1101. PubMed ID: 31589948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.
    Van Rappard DC; Mekkes JR
    Br J Dermatol; 2012 Jul; 167(1):206-8. PubMed ID: 22229974
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?
    Alhusayen R; Shear NH
    Am J Clin Dermatol; 2012 Oct; 13(5):283-91. PubMed ID: 22676319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.
    Arenbergerova M; Gkalpakiotis S; Arenberger P
    Int J Dermatol; 2010 Dec; 49(12):1445-9. PubMed ID: 21091684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.